Bone Bank Allografts

Bone Bank Allografts is a well-established, private player in the biologics and regenerative medicine sector, operating as a human tissue processor and distributor. With a 30-year history, it has built a global distribution network and a significant clinical track record, serving spine, orthopedic, and trauma surgeons. The company operates an FDA-registered tissue bank, emphasizing quality, innovation, and service to the transplant community. Its business model focuses on processing donated tissue into a portfolio of surgical allografts for the medical market.

Proprietary human tissue processing platform for recovery, sterilization, preservation, and shaping of bone and soft tissue allografts, with a focus on maintaining biological properties and ensuring safety.

BBA competes in a crowded allograft market against large, diversified medical device companies (e.g., Medtronic, Stryker) that have their own tissue processing divisions, as well as other independent tissue banks and non-biological synthetic bone graft substitutes. Its differentiation is based on its long-standing reputation, focus on service, and custom product capabilities.